187 related articles for article (PubMed ID: 27142037)
21. The Diagnosis and Management of Neurofibromatosis Type 1.
Ly KI; Blakeley JO
Med Clin North Am; 2019 Nov; 103(6):1035-1054. PubMed ID: 31582003
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.
Ruggieri M; Praticò AD; Evans DG
Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012
[TBL] [Abstract][Full Text] [Related]
23. [Neurofibromatosis type 1 and hypertension in pediatrics: case report].
Demarchi I; Genoni G; Prodam F; Petri A; Busti A; Cortese L; Negro M; Bellone S; Acucella G; Bona G
Minerva Pediatr; 2011 Aug; 63(4):335-9. PubMed ID: 21909069
[TBL] [Abstract][Full Text] [Related]
24. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
[TBL] [Abstract][Full Text] [Related]
25. [Neurofibromatosis].
Matthies C; Rampeltshammer E; Breun M
Fortschr Neurol Psychiatr; 2023 May; 91(5):213-232. PubMed ID: 37192611
[TBL] [Abstract][Full Text] [Related]
26. [Clinical diagnosis of neurofibromatosis type 1].
Wolkenstein P; Zeller J
Presse Med; 1999 Dec; 28(39):2174-80. PubMed ID: 10629698
[TBL] [Abstract][Full Text] [Related]
27. The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features.
Ruggieri M; Polizzi A; Spalice A; Salpietro V; Caltabiano R; D'Orazi V; Pavone P; Pirrone C; Magro G; Platania N; Cavallaro S; Muglia M; Nicita F
Clin Genet; 2015 May; 87(5):401-10. PubMed ID: 25211147
[TBL] [Abstract][Full Text] [Related]
28. Sclerosing segmental neurofibromatosis.
Lee JS; Kim YC
J Dermatol; 2005 Apr; 32(4):303-5. PubMed ID: 15863856
[TBL] [Abstract][Full Text] [Related]
29. Neurofibromatosis: part 2--clinical management.
Batista PB; Bertollo EM; Costa Dde S; Eliam L; Cunha KS; Cunha-Melo JR; Darrigo Junior LG; Geller M; Gianordoli-Nascimento IF; Madeira LG; Mendes HM; Miranda DM; Mata-Machado NA; Morato EG; Pavarino ÉC; Pereira LB; Rezende NA; Rodrigues Lde O; Sette JB
Arq Neuropsiquiatr; 2015 Jun; 73(6):531-43. PubMed ID: 26083891
[TBL] [Abstract][Full Text] [Related]
30. Gliomas in patients with neurofibromatosis type 1.
Albers AC; Gutmann DH
Expert Rev Neurother; 2009 Apr; 9(4):535-9. PubMed ID: 19344304
[TBL] [Abstract][Full Text] [Related]
31. Multiple or familial café-au-lait spots is neurofibromatosis type 6: clarification of a diagnosis.
Madson JG
Dermatol Online J; 2012 May; 18(5):4. PubMed ID: 22630574
[TBL] [Abstract][Full Text] [Related]
32. Neurofibromatosis type 2.
Evans DG
Handb Clin Neurol; 2015; 132():87-96. PubMed ID: 26564072
[TBL] [Abstract][Full Text] [Related]
33. Nosological considerations of the neurofibromatoses.
Viskochil D; Carey JC
J Dermatol; 1992 Nov; 19(11):873-80. PubMed ID: 1293176
[TBL] [Abstract][Full Text] [Related]
34. Spinal neurofibromatosis with central nervous system involvement in a set of twin girls and a boy: further expansion of the phenotype.
Ruggieri M; Polizzi A; Salpietro V; Incorpora G; Nicita F; Pavone P; Falsaperla R; Nucifora C; Granata F; Distefano A; Padua L; Caltabiano R; Lanzafame S; Gabriele AL; Ortensi A; D'Orazi V; Panunzi A; Milone P; Mankad K; Platania N; Albanese V; Pavone V
Neuropediatrics; 2013 Oct; 44(5):239-44. PubMed ID: 23780384
[TBL] [Abstract][Full Text] [Related]
35. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
36. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
Sabol Z; Kipke-Sabol L
Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
[TBL] [Abstract][Full Text] [Related]
37. A case of agminated lentiginosis with multiple café-au-lait macules.
Lee JH; Kim SE; Park K; Son SJ; Song KY
Clin Exp Dermatol; 2007 Nov; 32(6):658-60. PubMed ID: 17725665
[TBL] [Abstract][Full Text] [Related]
38. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
[TBL] [Abstract][Full Text] [Related]
39. [Importance of multidisciplinary consultations for children with neurofibromatosis].
Bursztyn J; Rodriguez D
J Fr Ophtalmol; 1999 Nov; 22(9):959-62. PubMed ID: 10609170
[TBL] [Abstract][Full Text] [Related]
40. Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules.
Ben-Shachar S; Dubov T; Toledano-Alhadef H; Mashiah J; Sprecher E; Constantini S; Leshno M; Messiaen LM
J Am Acad Dermatol; 2017 Jun; 76(6):1077-1083.e3. PubMed ID: 28318682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
